77 participants
Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-10-26
- Start Date:
- 2018-04-13
- Completion:
- 2021-04-21
Conditions
- Peripheral T Cell Lymphoma
- PTCL
- Extranodal NK/T-cell Lymphoma
- Extranodal NK/T-cell Lymphoma, Nasal Type
- Extranodal NK T Cell Lymphoma
- Extranodal NK T Cell Lymphoma, Nasal
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- Angioimmunoblastic T-cell Lymphoma
- Angioimmunoblastic T-Cell Lymphoma Recurrent
- Angioimmunoblastic T-Cell Lymphoma Refractory
- Peripheral T-cell Lymphoma NOS
- Peripheral T-Cell Lymphoma, Not Otherwise Specified
- Peripheral T-Cell Lymphoma Refractory
- Anaplastic Large Cell Lymphoma
- Anaplastic Large Cell Lymphoma, ALK-Positive
- Anaplastic Large Cell Lymphoma, ALK-negative
- ALK-negative Anaplastic Large Cell Lymphoma
- ALK-Positive Anaplastic Large Cell Lymphoma
- Cutaneous T-cell Lymphoma
Interventions
- DRUG